UniProt ID | PGM2_HUMAN | |
---|---|---|
UniProt AC | Q96G03 | |
Protein Name | Phosphoglucomutase-2 | |
Gene Name | PGM2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 612 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Catalyzes the conversion of the nucleoside breakdown products ribose-1-phosphate and deoxyribose-1-phosphate to the corresponding 5-phosphopentoses. May also catalyze the interconversion of glucose-1-phosphate and glucose-6-phosphate. Has low glucose 1,6-bisphosphate synthase activity.. | |
Protein Sequence | MAAPEGSGLGEDARLDQETAQWLRWDKNSLTLEAVKRLIAEGNKEELRKCFGARMEFGTAGLRAAMGPGISRMNDLTIIQTTQGFCRYLEKQFSDLKQKGIVISFDARAHPSSGGSSRRFARLAATTFISQGIPVYLFSDITPTPFVPFTVSHLKLCAGIMITASHNPKQDNGYKVYWDNGAQIISPHDKGISQAIEENLEPWPQAWDDSLIDSSPLLHNPSASINNDYFEDLKKYCFHRSVNRETKVKFVHTSVHGVGHSFVQSAFKAFDLVPPEAVPEQKDPDPEFPTVKYPNPEEGKGVLTLSFALADKTKARIVLANDPDADRLAVAEKQDSGEWRVFSGNELGALLGWWLFTSWKEKNQDRSALKDTYMLSSTVSSKILRAIALKEGFHFEETLTGFKWMGNRAKQLIDQGKTVLFAFEEAIGYMCCPFVLDKDGVSAAVISAELASFLATKNLSLSQQLKAIYVEYGYHITKASYFICHDQETIKKLFENLRNYDGKNNYPKACGKFEISAIRDLTTGYDDSQPDKKAVLPTSKSSQMITFTFANGGVATMRTSGTEPKIKYYAELCAPPGNSDPEQLKKELNELVSAIEEHFFQPQKYNLQPKAD | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAAPEGSGL ------CCCCCCCCC | 31.55 | 19413330 | |
19 | Phosphorylation | DARLDQETAQWLRWD CCCCCHHHHHHHHCC | 20.65 | 20068231 | |
27 | Ubiquitination | AQWLRWDKNSLTLEA HHHHHCCCCCCHHHH | 41.29 | 21890473 | |
27 | Ubiquitination | AQWLRWDKNSLTLEA HHHHHCCCCCCHHHH | 41.29 | 22817900 | |
27 | Acetylation | AQWLRWDKNSLTLEA HHHHHCCCCCCHHHH | 41.29 | 26822725 | |
29 | Phosphorylation | WLRWDKNSLTLEAVK HHHCCCCCCHHHHHH | 28.59 | 25159151 | |
36 | Ubiquitination | SLTLEAVKRLIAEGN CCHHHHHHHHHHCCC | 48.84 | 32015554 | |
44 | Ubiquitination | RLIAEGNKEELRKCF HHHHCCCHHHHHHHH | 64.52 | 24816145 | |
59 | Phosphorylation | GARMEFGTAGLRAAM CCCCCHHHHHHHHHH | 23.91 | 23684312 | |
66 | Sulfoxidation | TAGLRAAMGPGISRM HHHHHHHHCCCCCCC | 6.94 | 30846556 | |
91 | Ubiquitination | GFCRYLEKQFSDLKQ HHHHHHHHHHHHHHH | 54.79 | 21890473 | |
91 | Ubiquitination | GFCRYLEKQFSDLKQ HHHHHHHHHHHHHHH | 54.79 | 21890473 | |
91 | Acetylation | GFCRYLEKQFSDLKQ HHHHHHHHHHHHHHH | 54.79 | 26822725 | |
153 | Ubiquitination | FVPFTVSHLKLCAGI CCCCCHHHHHHEEEE | 23.73 | - | |
153 | Ubiquitination | FVPFTVSHLKLCAGI CCCCCHHHHHHEEEE | 23.73 | 21890473 | |
153 | Acetylation | FVPFTVSHLKLCAGI CCCCCHHHHHHEEEE | 23.73 | - | |
163 | Phosphorylation | LCAGIMITASHNPKQ HEEEEEEEECCCCCC | 12.53 | 22167270 | |
165 | Phosphorylation | AGIMITASHNPKQDN EEEEEEECCCCCCCC | 18.36 | 29255136 | |
174 | Phosphorylation | NPKQDNGYKVYWDNG CCCCCCCCEEEECCC | 11.97 | 23403867 | |
186 | Phosphorylation | DNGAQIISPHDKGIS CCCCEEECCCHHHHH | 20.15 | 28857561 | |
194 | Ubiquitination | PHDKGISQAIEENLE CCHHHHHHHHHHCCC | 44.42 | - | |
231 | Ubiquitination | SINNDYFEDLKKYCF CCCCCHHHHHHHHHH | 57.09 | 23000965 | |
253 | Phosphorylation | TKVKFVHTSVHGVGH CCEEEEEECCCCCCH | 27.43 | 25850435 | |
254 | Phosphorylation | KVKFVHTSVHGVGHS CEEEEEECCCCCCHH | 9.38 | 25850435 | |
261 | Phosphorylation | SVHGVGHSFVQSAFK CCCCCCHHHHHHHHH | 22.60 | 25850435 | |
265 | Phosphorylation | VGHSFVQSAFKAFDL CCHHHHHHHHHHHCC | 30.30 | 25850435 | |
268 | Methylation | SFVQSAFKAFDLVPP HHHHHHHHHHCCCCC | 48.11 | - | |
268 | "N6,N6-dimethyllysine" | SFVQSAFKAFDLVPP HHHHHHHHHHCCCCC | 48.11 | - | |
292 | Acetylation | DPEFPTVKYPNPEEG CCCCCCCCCCCHHCC | 58.42 | 26822725 | |
292 | Ubiquitination | DPEFPTVKYPNPEEG CCCCCCCCCCCHHCC | 58.42 | 21890473 | |
292 | Ubiquitination | DPEFPTVKYPNPEEG CCCCCCCCCCCHHCC | 58.42 | 22817900 | |
293 | Phosphorylation | PEFPTVKYPNPEEGK CCCCCCCCCCHHCCC | 12.14 | 28102081 | |
304 | Phosphorylation | EEGKGVLTLSFALAD HCCCCEEEEEEEECC | 20.25 | 29255136 | |
306 | Phosphorylation | GKGVLTLSFALADKT CCCEEEEEEEECCCC | 11.84 | 23403867 | |
313 | Phosphorylation | SFALADKTKARIVLA EEEECCCCCCEEEEC | 30.40 | 23403867 | |
327 | Methylation | ANDPDADRLAVAEKQ CCCCCHHHEEEEEEC | 26.68 | 115487289 | |
333 | Ubiquitination | DRLAVAEKQDSGEWR HHEEEEEECCCCCEE | 50.06 | - | |
367 | Phosphorylation | KEKNQDRSALKDTYM HHHCCCHHHHHHHHH | 46.36 | 20068231 | |
370 | Ubiquitination | NQDRSALKDTYMLSS CCCHHHHHHHHHHHH | 47.98 | 23000965 | |
372 | Phosphorylation | DRSALKDTYMLSSTV CHHHHHHHHHHHHHH | 14.83 | 20068231 | |
373 | Phosphorylation | RSALKDTYMLSSTVS HHHHHHHHHHHHHHH | 13.24 | 20068231 | |
376 | Phosphorylation | LKDTYMLSSTVSSKI HHHHHHHHHHHHHHH | 13.87 | 20068231 | |
377 | Phosphorylation | KDTYMLSSTVSSKIL HHHHHHHHHHHHHHH | 28.94 | 20068231 | |
378 | Phosphorylation | DTYMLSSTVSSKILR HHHHHHHHHHHHHHH | 22.49 | 20068231 | |
380 | Phosphorylation | YMLSSTVSSKILRAI HHHHHHHHHHHHHHH | 26.46 | 20068231 | |
381 | Phosphorylation | MLSSTVSSKILRAIA HHHHHHHHHHHHHHH | 21.27 | 20068231 | |
410 | Ubiquitination | KWMGNRAKQLIDQGK CCCHHHHHHHHHCCC | 42.26 | 29967540 | |
447 | Phosphorylation | GVSAAVISAELASFL CCCHHHHHHHHHHHH | 14.75 | - | |
469 | Phosphorylation | SQQLKAIYVEYGYHI HHHHHHHHHHHCCCC | 7.65 | 22817900 | |
472 | Phosphorylation | LKAIYVEYGYHITKA HHHHHHHHCCCCEEE | 16.97 | 22817900 | |
481 | Phosphorylation | YHITKASYFICHDQE CCCEEECEEEECCHH | 11.21 | 21253578 | |
489 | Phosphorylation | FICHDQETIKKLFEN EEECCHHHHHHHHHH | 32.25 | - | |
492 | Ubiquitination | HDQETIKKLFENLRN CCHHHHHHHHHHHHC | 55.33 | 19608861 | |
492 | Acetylation | HDQETIKKLFENLRN CCHHHHHHHHHHHHC | 55.33 | 19608861 | |
503 | Ubiquitination | NLRNYDGKNNYPKAC HHHCCCCCCCCCCCC | 38.84 | - | |
512 | Acetylation | NYPKACGKFEISAIR CCCCCCCCEEEEHHH | 39.44 | 25953088 | |
512 | Ubiquitination | NYPKACGKFEISAIR CCCCCCCCEEEEHHH | 39.44 | 32015554 | |
525 | Phosphorylation | IRDLTTGYDDSQPDK HHHCCCCCCCCCCCC | 17.93 | 32142685 | |
528 | Phosphorylation | LTTGYDDSQPDKKAV CCCCCCCCCCCCCCC | 40.49 | 32142685 | |
532 | Acetylation | YDDSQPDKKAVLPTS CCCCCCCCCCCCCCC | 49.68 | 25953088 | |
533 | Ubiquitination | DDSQPDKKAVLPTSK CCCCCCCCCCCCCCC | 51.62 | 29967540 | |
538 | Phosphorylation | DKKAVLPTSKSSQMI CCCCCCCCCCCCCEE | 44.63 | 27251275 | |
539 | Phosphorylation | KKAVLPTSKSSQMIT CCCCCCCCCCCCEEE | 28.71 | 24719451 | |
541 | Phosphorylation | AVLPTSKSSQMITFT CCCCCCCCCCEEEEE | 26.10 | 20068231 | |
542 | Phosphorylation | VLPTSKSSQMITFTF CCCCCCCCCEEEEEE | 27.75 | 20068231 | |
546 | Phosphorylation | SKSSQMITFTFANGG CCCCCEEEEEEECCC | 15.98 | 24719451 | |
548 | Phosphorylation | SSQMITFTFANGGVA CCCEEEEEEECCCEE | 17.12 | 20068231 | |
556 | Phosphorylation | FANGGVATMRTSGTE EECCCEEEEECCCCC | 12.55 | 20068231 | |
567 | Acetylation | SGTEPKIKYYAELCA CCCCCCEEEEEECCC | 38.03 | 25953088 | |
568 | Phosphorylation | GTEPKIKYYAELCAP CCCCCEEEEEECCCC | 16.04 | 22817900 | |
569 | Phosphorylation | TEPKIKYYAELCAPP CCCCEEEEEECCCCC | 6.65 | - | |
585 | Acetylation | NSDPEQLKKELNELV CCCHHHHHHHHHHHH | 43.85 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PGM2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PGM2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PGM2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CK054_HUMAN | C11orf54 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Exploring proteomes and analyzing protein processing by massspectrometric identification of sorted N-terminal peptides."; Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,Thomas G.R., Vandekerckhove J.; Nat. Biotechnol. 21:566-569(2003). Cited for: PROTEIN SEQUENCE OF 2-14, AND ACETYLATION AT ALA-2. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-492, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165, AND MASSSPECTROMETRY. |